Company Monitoring Page for Otsuka

job ratings for Otsuka

08/14/22
industry:
pharma
company:
Otsuka
job rating:
1
So disorganized
02/06/21
industry:
Big Pharma
company:
Otsuka
job rating:
1
It’s bizarroworld.
11/15/20
industry:
Big Pharma
company:
Otsuka
job rating:
1
Seriously unqualified execs generating redundant work to look busy for Japan. Leadership looks the other way at middle mgmt’s incompetence. Work done mostly by contractors due to turnover. Miserable employees.
09/07/20
industry:
pharmaceutical sales
job title:
Sales rep - Nephrology
company:
Otsuka
job rating:
1
No pipeline. Highly unorganized. Inept Sr. Management. Poor leadership.
03/28/20
industry:
Big Pharma
job title:
sales rep
company:
Otsuka
job rating:
1
Assholes in management...micromanagment, incompetent execs, nothing new to talk about
01/29/20
industry:
Big Pharma
job title:
salesrep
company:
Otsuka
job rating:
1
Boring as hell, nothing new to talk about, stupid management
01/07/20
industry:
pharma
company:
Otsuka
job rating:
1
Poor leadership
07/28/19
industry:
Big Pharma
job title:
Neuroscience representative
company:
Otsuka
job rating:
1
Nothing new to talk about, no more access to doctors, more sales pressure
03/27/17
industry:
pharmaceutical sales
company:
Otsuka
job rating:
1
Culture; pipeline; upper management

latest headlines for company on cafepharma

Japan's Otsuka Pharma & ICU Medical sign $200 M deal to create joint venture in North America for manufacturing IV solutions
BioSpectrum Asia
Wed, 11/13/24 - 11:08 am
Tags:
Otsuka, ICU Medical, IVs
Otsuka eyes early filing of IgAN drug after phase 3 readout
Pharmaphorum
Tue, 10/22/24 - 11:19 am
Tags:
Otsuka, anti-APRIL, sibeprenlimab, IgA nephropathy, clinical trials
Abilify Asimtufii campaign uses 3D CGI to detail journey of bipolar I patients
Medical Marketing and Media
Mon, 09/9/24 - 07:14 pm
Tags:
pharma marketing, DTC advertising, Ability Asimtufii, Otsuka, Lundbeck
Otsuka Pays Up to $1.1B to Buy Jnana, Adds Drug Discovery Capabilities
BioSpace
Thu, 08/1/24 - 11:26 am
Tags:
Otsuka, M&A, Jnana Therapeutics, drug discovery
Why Otsuka launched a digital health company
Medical Marketing and Media
Mon, 06/10/24 - 11:13 am
Tags:
Otsuka, Otsuka Precision Health, Medtech, digital therapeutics, major depressive disorder
Otsuka defies digital health downturn with new company
BioPharma Dive
Thu, 05/30/24 - 11:07 am
Tags:
Otsuka, Medtech, digital health, major depressive disorder, Otsuka Precision Health
Otsuka and Lundbeck report data from three PTSD treatment trials
Clinical Trials Arena
Wed, 05/29/24 - 11:52 am
Tags:
Otsuka, Lundbeck, PTSD, clinical tirals, brexpiprazole-sertraline
Otsuka Drops Alzheimer’s Agitation Drug Following Phase III Failure
BioSpace
Wed, 05/22/24 - 11:20 am
Tags:
Otsuka, Alzheimer's disease, Alzheimer's agitation, clinical trials, AVP-786
3 patent expirations in 2024 and how companies are pivoting
Pharma Voice
Wed, 04/17/24 - 11:13 am
Tags:
patents, patent cliff, Bayer, J&J, Xarelto, Novo Nordisk, Victoza, Otsuka, Lundbeck, Abilify
Otsuka Drug Candidate Fails Phase III Alzheimer’s Agitation Study
BioSpace
Tue, 02/13/24 - 11:27 am
Tags:
Otsuka, clinical trials, AVP-786, Alzheimer's agitation
FDA rules Otsuka marketing claim overstates Rexulti efficacy, threatening cornerstone of huge TV push
Fierce Pharma
Tue, 11/14/23 - 11:19 am
Tags:
Otsuka, FDA, Rexulti, pharma marketing, clinical depression
Otsuka reports positive data from two Phase III ADHD treatment trials
Clinical Trials Arena
Mon, 10/30/23 - 11:44 am
Tags:
Otsuka, clinical trials, ADHD, centanafadine
Otsuka, Shape Ink Potential $1.5B Deal to Develop Eye AAV Gene Therapies
BioSpace
Fri, 09/8/23 - 10:11 am
Tags:
Otsuka, Shape Therapeutics, gene therapy, AAV gene therapy, RNA editing, ocular diseases
Evaluating renal denervation rivals, FDA advisory panel backs ReCor, shuns Medtronic
Fierce Biotech
Fri, 08/25/23 - 09:51 am
Tags:
Medtech, FDA, renal denervation, Otsuka, Recor, Medtronic, hypertension
Sumitomo, Otsuka’s Schizophrenia Candidate Fails Phase III Trials
BioSpace
Mon, 07/31/23 - 09:50 pm
Tags:
Sumitomo Pharma, Otsuka, clinical trials, ulotaront, schizophrenia
Hope springs for April inhibition
EP Vantage
Tue, 06/13/23 - 10:27 am
Tags:
Novartis, Chinook Therapeutics, April inhibition, M&A, Vera Therapeutics, Otsuka, RemeGen, Alpine Immune Sciences, Akso Biopharmaceutical, Aurinia Pharmaceuticals
Japan's Otsuka Pharma-Lundbeck Partnered Depression Drug Gets FDA Approval For Alzheimer's Agitation
Yahoo/Benzinga
Thu, 05/11/23 - 08:53 pm
Tags:
Otsuka, Lundbeck, FDA, Rexulti, Alzheimer's agitation
Otsuka, Lundbeck gain FDA nod for longer-acting version of schizophrenia drug Abilify
Fierce Pharma
Mon, 05/1/23 - 10:04 am
Tags:
Otsuka, Lundbeck, FDA, Abilify, Asimtufii, bipolar disorder
Sunovion, Otsuka randomize first patient for GAD Phase II/III study
Clinical Trials Arena
Thu, 04/27/23 - 10:27 am
Tags:
Sunovion, Otsuka, clinicat trials, ulotaront, generalized anxiety disorder
FDA advisers back Lundbeck and Otsuka's Rexulti in Alzheimer's disease agitation
Fierce Pharma
Sun, 04/16/23 - 11:17 pm
Tags:
Lundbeck, Otsuka, Rexulti, Alzheimer's disease, FDA

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.